Survival Benefit for Kidneys From Incompatible Living Donors

Share this content:
Survival Benefit for Kidneys From Incompatible Living Donors
Survival Benefit for Kidneys From Incompatible Living Donors

THURSDAY, March 10, 2016 (HealthDay News) -- In what researchers are calling a possible "paradigm shift," a new study shows kidney disease patients may live longer if they receive a transplant from an incompatible living donor rather than wait for a good match. The research was published in the March 10 issue of the New England Journal of Medicine.

Dorry Segev, M.D., Ph.D., an associate professor of surgery at the Johns Hopkins University School of Medicine in Baltimore, and colleagues followed 1,025 sensitized patients who received a kidney from an incompatible donor at one of 22 transplant centers in the United States. They compared the patients' survival with that of two control groups: 5,125 patients on the transplant waiting list who eventually received a kidney; and 5,125 of wait-list patients who had to remain on dialysis.

After eight years, 76.5 percent of the incompatible-donor patients were still alive. That compared with 43.9 percent of dialysis patients and 62.9 percent of those who ultimately received a deceased-donor organ.

The desensitization process, including immunosuppressant medication, also adds about $20,000 to $30,000 to the cost of getting a transplant, according to the University of Wisconsin's transplant center, one of the U.S. programs that performs the procedure. But it's still far cheaper than dialysis in the long run, Segev said in a news release from Johns Hopkins.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »